BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38198060)

  • 1. Comparison of tracer kinetic models for
    Smith NJ; Green MA; Bahler CD; Tann M; Territo W; Smith AM; Hutchins GD
    EJNMMI Res; 2024 Jan; 14(1):6. PubMed ID: 38198060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Tracer Kinetic Models for 68Ga-PSMA-11 PET in Intermediate Risk Primary Prostate Cancer Patients.
    Smith NJ; Green MA; Bahler CD; Tann M; Territo W; Smith AM; Hutchins GD
    Res Sq; 2023 Nov; ():. PubMed ID: 37961116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [
    Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):896-906. PubMed ID: 37889299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of parametric imaging and SUV imaging with [
    Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic modeling of
    Ringheim A; Campos Neto GC; Anazodo U; Cui L; da Cunha ML; Vitor T; Martins KM; Miranda ACC; de Barboza MF; Fuscaldi LL; Lemos GC; Colombo Junior JR; Baroni RH
    EJNMMI Res; 2020 Feb; 10(1):12. PubMed ID: 32140850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Patlak Reconstruction of [
    Rasul S; Geist BK; Einspieler H; Fajkovic H; Shariat SF; Schmitl S; Mitterhauser M; Bartosch R; Langsteger W; Baltzer PAT; Beyer T; Ferrara D; Haug AR; Hacker M; Rausch I
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric dynamic whole-body PSMA PET/CT using [
    Dias AH; Jochumsen MR; Zacho HD; Munk OL; Gormsen LC
    EJNMMI Res; 2023 Apr; 13(1):31. PubMed ID: 37060394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic modeling and parametric imaging of
    Yuan H; Zhang G; Sun T; Ren J; Zhang Q; Xiang Z; Liu E; Jiang L
    Med Phys; 2024 Jan; 51(1):156-166. PubMed ID: 38043120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.
    Sachpekidis C; Eder M; Kopka K; Mier W; Hadaschik BA; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1288-99. PubMed ID: 26753602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early dynamic imaging in
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer.
    Sachpekidis C; Kopka K; Eder M; Hadaschik BA; Freitag MT; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2016 Nov; 41(11):e473-e479. PubMed ID: 27607173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of [
    Strauss DS; Sachpekidis C; Kopka K; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4472-4482. PubMed ID: 34110436
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sachpekidis C; Bäumer P; Kopka K; Hadaschik BA; Hohenfellner M; Kopp-Schneider A; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):904-912. PubMed ID: 29362859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging.
    Schmuck S; Mamach M; Wilke F; von Klot CA; Henkenberens C; Thackeray JT; Sohns JM; Geworski L; Ross TL; Wester HJ; Christiansen H; Bengel FM; Derlin T
    Clin Nucl Med; 2017 Jun; 42(6):e286-e293. PubMed ID: 28221194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.
    Alhuseinalkhudhur A; Lubberink M; Lindman H; Tolmachev V; Frejd FY; Feldwisch J; Velikyan I; Sörensen J
    EJNMMI Res; 2020 Mar; 10(1):21. PubMed ID: 32201920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
    Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified Methods for Quantification of
    Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative
    Schaefferkoetter JD; Wang Z; Stephenson MC; Roy S; Conti M; Eriksson L; Townsend DW; Thamboo T; Chiong E
    EJNMMI Res; 2017 Dec; 7(1):25. PubMed ID: 28324340
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sachpekidis C; Pan L; Hadaschik BA; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Am J Nucl Med Mol Imaging; 2018; 8(5):351-359. PubMed ID: 30510852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.